UCPH spin-out to develop the future's obesity medicine with Novo Nordisk

Last year, Danish drug group Novo Nordisk set a strategy that involved bringing in more external innovation to the company. This year, the firm has already been in Germany, England and especially the US to find new partners.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo's innovation hunter brings back abandoned project
For subscribers
Novo Seeds starts new consulting company: "The need is huge"
For subscribers